CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Xiamen Kingdomway Group Co Company Snapshot
Xiamen Kingdomway Group Co operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xiamen Kingdomway Group Co with three other companies in this sector in China: Zhejiang Jiuzhou Pharmaceutical Co Ltd (2016 sales of 1.65 billion Chinese Renmimbi [US$242.04 million] ), Hainan Haiyao Company Limited (1.54 billion Chinese Renmimbi [US$226.05 million] of which 68% was BPC), and Yabao Pharmaceutical Group Company Limited (1.81 billion Chinese Renmimbi [US$264.45 million] of which 73% was Pharrmaceutical Manufacturing).

Sales Analysis. Xiamen Kingdomway Group Co reported sales of 1.66 billion Chinese Renmimbi (US$243.47 million) for the year ending December of 2016. This represents an increase of 38.1% versus 2015, when the company's sales were 1.20 billion Chinese Renmimbi. This was the third consecutive year of growth at Xiamen Kingdomway Group Co.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Xiamen Kingdomway Group Co
  Stock Performance Chart for Xiamen Kingdomway Group Co
 
  Stock Data: Recent Stock Performance:
  Current Price (6/16/2017): 12.81
(Figures in Chinese Renmimbi)
1 Week -0.4%   13 Weeks 4.7%  
4 Weeks -10.7%   52 Weeks -17.8%  
 
Xiamen Kingdomway Group Co Key Data:
  Ticker: 002626 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 1,662,717,965
(Year Ending Jan 2017).
Employees: 1,689
  Currency: Chinese Renmimbi Market Cap: 7,897,133,485
  Fiscal Yr Ends: December Shares Outstanding: 616,481,927
  Share Type: A Gu Closely Held Shares: 430,567,077
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.